We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Hydroxycitrate Potentially More Effective Than Citrate for Kidney Stones

By LabMedica International staff writers
Posted on 18 Aug 2016
Print article
Image: A kidney stone (yellow) composed of calcium oxalate showing sharp edges (Photo courtesy of Wikimedia Commons).
Image: A kidney stone (yellow) composed of calcium oxalate showing sharp edges (Photo courtesy of Wikimedia Commons).
The chemical hydroxycitrate (HCA) was shown in a recent study to be more effective for treating calcium oxalate kidney stones than the commonly used compound potassium citrate.

Calcium oxalate monohydrate is the principal component of human kidney stones and citrate (CA) is an often-used therapy, but hydroxycitrate (HCA) is not. In a study published in the August 8, 2016, online edition of the journal Nature, investigators at the University of Houston (TX, USA) used techniques of bulk crystallization, in situ atomic force microscopy, and density functional theory to compare the capacity of CA and HCA to prevent or even reverse the growth of calcium oxalate crystals.

The investigators reported finding a mechanism that differed from classical theory in that inhibitor adsorption on crystal surfaces induced dissolution of the crystal under specific conditions rather than merely reducing the rate of crystal growth. This phenomenon occurred even in supersaturated solutions where the inhibitor concentration was three orders of magnitude less than that of the solute.

Decrease in crystal size was explained by a hypothesis, generated from atomic force microscopy observations, that inhibitor–crystal interactions imparted localized strain to the crystal lattice and that oxalate and calcium ions were released into solution to alleviate this strain.

For HCA to function as a kidney stone treatment, it must be excreted in urine. The investigators reported that HCA ingested by non-stone-forming humans at an often-recommended dose led to substantial urinary excretion. In vitro assays using human urine revealed that HCA was as effective an inhibitor of nucleation of calcium oxalate monohydrate nucleation as was CA. These findings supported further exploration of the clinical potential of hydroxycitrate as an alternative treatment to citrate for kidney stones.

Senior author Dr. Jeffrey D. Rimer, associate professor of chemical engineering at the University of Houston, said that, "While this research established the groundwork to design an effective drug, questions remain. Long-term safety, dosage, and additional human trials are needed. But our initial findings are very promising. If it works in vivo, similar to our trials in the laboratory, HCA has the potential to reduce the incidence rate of people with chronic kidney stone disease."

Related Links:
University of Houston

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
One Step HbA1c Measuring System
GREENCARE A1c
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Xylazine Immunoassay Test
Xylazine ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Microbiology

view channel
Image: The new platform is designed to perform blood-based diagnoses of nontuberculosis mycobacteria (Photo courtesy of 123RF)

New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours

Breathing in nontuberculous mycobacteria (NTM) is a common experience for many people. These bacteria are present in water systems, soil, and dust all over the world and usually don't cause any problems.... Read more

Industry

view channel
Image: These new assays are being developed for use on the recently introduced DxI 9000 Immunoassay Analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics (Brea, CA, USA) and Fujirebio Diagnostics (Tokyo, Japan) have expanded their partnership focused on the development, manufacturing and clinical adoption of neurodegenerative... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.